# ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer

> **NCT02582125** · PHASE2 · COMPLETED · sponsor: **Ono Pharmaceutical Co., Ltd.** · enrollment: 53 (actual)

## Conditions studied

- Advanced Non-small Cell Lung Cancer

## Interventions

- **DRUG:** ONO-4538

## Key facts

- **NCT ID:** NCT02582125
- **Lead sponsor:** Ono Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-27
- **Primary completion:** 2021-01-04
- **Final completion:** 2021-12-31
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2025-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02582125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02582125, "ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02582125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*